When we consider the major cannabinoids, cannabichromene (CBC)
is like the ugly duckling. It doesn’t get a lot of praise, or attention
for that matter, but it has shown to have profound benefits. Similar
to cannbidiol (CBD) and tetrahydrocannabinol (THC), CBC stems from the all-important cannabigerolic acid (CBGA).
In order to get cannabichromene, decarboxylation must occur. Over time, or quickly if exposed to heat, the CBCA will lose a molecule of CO2; at this point it is considered CBC. The same process applies when developing THC and CBD.
Although cannabichromene isn’t the most popular cannabinoid, research suggests CBC could be very beneficial. According to Halent Labs, a top lab-testing facility, it’s believed to inhibit inflammation and pain. In addition, it is believed to stimulate bone growth.
One of the most intriguing findings about cannabichromene is it’s relationship with cancer. CBC is believed to have anti-proliferative effects, meaning it inhibits the growth of cancerous tumors. This could be a result of its interaction with anandamide.
Anandamide is an endocannabinoid, which means our body produces it naturally. It effects the CB1 receptors, as well as the CB2 receptors, and has been found to fight against human breast cancer. CBC inhibits the uptake of anandamide, which allows it to stay in the blood stream longer.
Not only does CBC have benefits of its own, but it seems to work with the other cannabinoids to produce a synergistic effect; it gives merit to the saying, “the whole is greater than the sum of its parts.” Even though cannabichromene is found in much smaller concentrations than THC and CBD, its importance should not be overlooked.
More From: Medical Jane
